CorVel (NASDAQ: CRVL) is one of 46 publicly-traded companies in the “Healthcare Facilities & Services” industry, but how does it weigh in compared to its competitors? We will compare CorVel to similar businesses based on the strength of its profitability, dividends, institutional ownership, analyst recommendations, earnings, risk and valuation.
This table compares CorVel and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of recent recommendations and price targets for CorVel and its competitors, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
As a group, “Healthcare Facilities & Services” companies have a potential upside of 2.04%. Given CorVel’s competitors higher possible upside, analysts clearly believe CorVel has less favorable growth aspects than its competitors.
Institutional & Insider Ownership
43.8% of CorVel shares are owned by institutional investors. Comparatively, 70.4% of shares of all “Healthcare Facilities & Services” companies are owned by institutional investors. 51.0% of CorVel shares are owned by company insiders. Comparatively, 15.2% of shares of all “Healthcare Facilities & Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Valuation and Earnings
This table compares CorVel and its competitors top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|CorVel||$518.69 million||$29.47 million||27.64|
|CorVel Competitors||$6.40 billion||$199.81 million||482.05|
CorVel’s competitors have higher revenue and earnings than CorVel. CorVel is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Volatility and Risk
CorVel has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, CorVel’s competitors have a beta of 0.70, indicating that their average stock price is 30% less volatile than the S&P 500.
CorVel competitors beat CorVel on 7 of the 10 factors compared.
CorVel Corporation (Corvel) is a provider of workers’ compensation solutions for employers, third party administrators, insurance companies and government agencies. The Company offers its services as a bundled solution, which includes claims management, as a standalone service, or as add-on services to existing customers. The Company offers its services as a bundled solution, which includes claims management, as a standalone service, or as add-on services to existing customers. The Company’s network solutions include bill review, preferred provider organization (PPO) management, professional review, provider reimbursement, pharmacy services, directed care services, medicare solutions and clearinghouse services. The Company’s patient management services include claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, life care planning, disability management, liability claims management and auto claims management.
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.